Zhao Weilin was elected as a non-independent director.
The First Tractor Company Limited (00038) issued an announcement that Mr. Zhao Weilin (Mr. Zhao) was elected at the extraordinary general meeting as...
FIRST TRACTOR (00038) announces that at the extraordinary general meeting, Mr. Zhao Weilin (Mr. Zhao) was elected as the non-independent director of the 9th Board of Directors of the company. His term will be from the date of approval at the extraordinary general meeting until the end of the 9th Board of Directors term.
The Board of Directors further announced that on the same day at the 32nd meeting of the 9th Board of Directors, Mr. Zhao was elected as the Chairman and legal representative of the 9th Board of Directors of the company. He will also serve as a member and chairman of the Strategy, Investment and Sustainable Development Committee of the Board of Directors, and a member of the Nomination Committee. These positions will be effective from the date of approval by the Board of Directors and will end at the end of the 9th Board of Directors term.
The Board of Directors further announced that according to the Securities Listing Rules of The Stock Exchange of Hong Kong Limited, the company must appoint and maintain two authorized representatives as the main communication channel with the Stock Exchange. Therefore, the company appoints Mr. Zhao to replace Mr. Lai as the authorized representative of the company.
 Related Articles 

HK Stock Market Move  | CEB BANK (06818) falls nearly 5% after performance announcement, with both revenue and profit decreasing in the first three quarters. Fair value changes are putting pressure on profit.

HK Stock Market Move  | BOAN BIOTECH (06955) surged more than 4%, and the enrollment of all patients in the Chinese Phase III clinical trial of Navulimab monoclonal antibody is complete.

HK Stock Market Move  | ASCLETIS-B(01672) now up more than 4%. Subcutaneous injection of the glucagon-like peptide-1 receptor agonist ASC36 has entered the clinical development stage.
HK Stock Market Move  | CEB BANK (06818) falls nearly 5% after performance announcement, with both revenue and profit decreasing in the first three quarters. Fair value changes are putting pressure on profit.

HK Stock Market Move  | BOAN BIOTECH (06955) surged more than 4%, and the enrollment of all patients in the Chinese Phase III clinical trial of Navulimab monoclonal antibody is complete.

HK Stock Market Move  | ASCLETIS-B(01672) now up more than 4%. Subcutaneous injection of the glucagon-like peptide-1 receptor agonist ASC36 has entered the clinical development stage.

RECOMMEND

First in History: NVIDIA’s Market Capitalization Tops $5 Trillion
30/10/2025

Congressional Budget Office Estimates Government Shutdown Has Cost the U.S. Economy $18 Billion
30/10/2025

Wall Street on China’s Internet Sector: Distinct Investment Opportunities in AI and Gaming; Caution on E‑commerce
30/10/2025


